Primary (genetic) pediatric dystonia is characterized by sustained or intermittent muscle contractions that cause abnormal movements or postures. The report states an overall prevalence of approximately 16.4 in 100,000 children worldwide. Genetic causes are diverse and include pathogenic variants in genes such as TOR1A, the gene associated with DYT-TOR1A dystonia.
This article presents a case report of a toddler with early-onset, rapidly progressive, and refractory status dystonicus. The child’s dystonia evolved to a level described as status dystonicus that failed to respond to standard medical therapies and supportive measures, prompting escalation of care. The combination of very young age, rapid progression, and refractoriness made the clinical course atypical and clinically challenging.
Genetic testing identified a maternally inherited pathogenic variant in TOR1A, described as c.907_909del (p.Glu303del). This genetic diagnosis confirmed the etiology as DYT-TOR1A dystonia in this patient and provided a molecular explanation for the primary dystonia phenotype observed.
According to the case report, the child’s dystonia was refractory to multiple optimized medications and to continuous infusions. The report does not specify the exact agents, dosing regimens, or durations of each medical therapy attempted; it records only that medical and infusion-based strategies were optimized yet insufficient to control the status dystonicus. This degree of refractoriness was a primary driver for consideration of surgical intervention.
Given the failure of medical treatments, the clinical team proceeded with surgical therapy. Bilateral deep brain stimulation (DBS) targeting the globus pallidus interna (GPi) was performed and, per the report, provided symptomatic relief of the child’s status dystonicus. The case emphasizes that DBS produced meaningful improvement in the refractory dystonic state when other measures had failed. The report does not provide numerical outcome scales or long-term follow-up data in the abstract, and such details are not reported in the provided source excerpt.
The authors note that the patient’s atypical presentation and young age complicated prediction of expected outcomes and required unique preoperative planning considerations before placement of bilateral GPi DBS. While the source indicates that planning was individualized for this young patient, the abstract does not enumerate the specific planning steps or technical modifications undertaken. Those details were not reported in the source abstract provided here.
This case highlights several practical and counseling challenges clinicians face when managing very young patients with genetically driven, rapidly progressive, and refractory dystonia. Key issues raised in the report include:
The abstract frames the case as illustrative of the complex decision-making and multidisciplinary coordination required for similarly affected children.
This case report is published in Neurology (2026 Aug 25;107(4):e214878). The authors include Hadley W. Ressler and colleagues from Pediatric Neurology, Medical Genetics, Neurosurgery, and Neurology divisions at Wake Forest School of Medicine. The PubMed identifier is PMID 42551000 and the DOI is 10.1212/WNL.0000000000214878.
Note: The abstract provided for this rewrite does not include detailed medication names, dosing, imaging findings, intraoperative technique, quantitative outcome measures, or long-term follow-up data. Those specifics were not reported in the source excerpt used for this summary.